Virginiamycin S1

Research use only, not for human use.

Virginiamycin S1 is a streptozotocin B antibiotic produced by Streptomyces verticillioides, which has antibacterial activity by inhibiting bacterial protein synthesis at the level of aminoacyl-tRNA binding and peptide bond formation.

Virginiamycin S1 is a cyclic hexadepsipeptide antibiotic, inhibits bacterial protein synthesis at the level of aminoacyl-tRNA binding and peptide bond formation. Virginiamycin S1 belongs to the type B compounds in the streptogramin family and is produced by Streptomyces virginiae, shows a strong bactericidal activity against a wide range of Gram-positive bacteria. Virginiamycin S1 together with virginiamycin M1 is more effective in treat multidrug-resistant bacterial infections.

——

——

——

Microbiology/Virology

Antibiotic

Antibiotic | Antibacterial

——

——

23152-29-6

823.89

C43H49N7O10

>98% (HPLC)

——

O=C1N2[C@](C(=O)N[C@H](C(=O)O[C@H](C)[C@H](NC(=O)C3=C(O)C=CC=N3)C(=O)N[C@H](CC)C(=O)N4[C@](C(=O)N(C)[C@H]1CC5=CC=CC=C5)(CCC4)[H])C6=CC=CC=C6)(CC(=O)CC2)[H]

——

(-20℃)

With Ice Pack

≥ 2 years